Univec, Inc. (UNVC)
OTCMKTS
· Delayed Price · Currency is USD
0.0022
0.00 (0.00%)
Mar 6, 2026, 12:34 PM EST
Univec Revenue
Univec had revenue of $10.71K in the quarter ending June 30, 2011, with 27.14% growth. This brings the company's revenue in the last twelve months to $28.63K, up 46.77% year-over-year. In the year 2006, Univec had annual revenue of $21.46K, down -73.64%.
Revenue (ttm)
28.63K
Revenue Growth
+46.77%
P/S Ratio
185.05
Revenue / Employee
9.54K
Employees
3
Market Cap
5.30M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2006 | 21.46K | -59.94K | -73.64% |
| Dec 31, 2005 | 81.40K | -246.43K | -75.17% |
| Dec 31, 2004 | 327.83K | -611.92K | -65.12% |
| Dec 31, 2003 | 939.75K | -1.95M | -67.45% |
| Dec 31, 2002 | 2.89M | -1.02M | -26.06% |
| Dec 31, 2001 | Pro | Pro | Pro |
| Dec 31, 2000 | Pro | Pro | Pro |
| Dec 31, 1999 | Pro | Pro | Pro |
| Dec 31, 1998 | Pro | Pro | Pro |
| Dec 31, 1997 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BioCorRx | 948.36K |
| Regional Health Properties | 37.30M |
| Xcelerate | 2.70M |
| Veltex | 70.13M |
| Selectis Health | 42.17M |
| Mid-Atlantic Home Health Network | 27.00M |
| Stem Cell Authority | 3.33M |
| HealthLynked | 2.37M |